FR2949044B1 - Composition comprenant une fraction d'insaponifiable - Google Patents

Composition comprenant une fraction d'insaponifiable Download PDF

Info

Publication number
FR2949044B1
FR2949044B1 FR0955643A FR0955643A FR2949044B1 FR 2949044 B1 FR2949044 B1 FR 2949044B1 FR 0955643 A FR0955643 A FR 0955643A FR 0955643 A FR0955643 A FR 0955643A FR 2949044 B1 FR2949044 B1 FR 2949044B1
Authority
FR
France
Prior art keywords
composition
unsaponifiable
fraction
composition including
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0955643A
Other languages
English (en)
Other versions
FR2949044A1 (fr
Inventor
Philippe Msika
David Daguet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Expanscience SA
Original Assignee
Laboratoires Expanscience SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Expanscience SA filed Critical Laboratoires Expanscience SA
Priority to FR0955643A priority Critical patent/FR2949044B1/fr
Priority to US13/389,847 priority patent/US9282759B2/en
Priority to ES10742154.7T priority patent/ES2658865T3/es
Priority to EP10742154.7A priority patent/EP2464248B1/fr
Priority to PCT/EP2010/061764 priority patent/WO2011018501A2/fr
Publication of FR2949044A1 publication Critical patent/FR2949044A1/fr
Application granted granted Critical
Publication of FR2949044B1 publication Critical patent/FR2949044B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet une composition, notamment cosmétique, nutraceutique, dermatologique, pharmaceutique ou alimentaire, comprenant au moins un extrait d'insaponifiable, un médicament comprenant une telle composition, l'utilisation d'une telle composition, une méthode de traitement consistant à administrer une telle composition et un procédé comprenant l'administration d'une telle composition.
FR0955643A 2009-08-12 2009-08-12 Composition comprenant une fraction d'insaponifiable Active FR2949044B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0955643A FR2949044B1 (fr) 2009-08-12 2009-08-12 Composition comprenant une fraction d'insaponifiable
US13/389,847 US9282759B2 (en) 2009-08-12 2010-08-12 Composition including an unsaponifiable fraction
ES10742154.7T ES2658865T3 (es) 2009-08-12 2010-08-12 Composición que incluye una fracción insaponificable
EP10742154.7A EP2464248B1 (fr) 2009-08-12 2010-08-12 Composition comprenant une fraction d'insaponifiable
PCT/EP2010/061764 WO2011018501A2 (fr) 2009-08-12 2010-08-12 Composition comprenant une fraction non saponifiable

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0955643A FR2949044B1 (fr) 2009-08-12 2009-08-12 Composition comprenant une fraction d'insaponifiable

Publications (2)

Publication Number Publication Date
FR2949044A1 FR2949044A1 (fr) 2011-02-18
FR2949044B1 true FR2949044B1 (fr) 2021-05-07

Family

ID=42077317

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0955643A Active FR2949044B1 (fr) 2009-08-12 2009-08-12 Composition comprenant une fraction d'insaponifiable

Country Status (5)

Country Link
US (1) US9282759B2 (fr)
EP (1) EP2464248B1 (fr)
ES (1) ES2658865T3 (fr)
FR (1) FR2949044B1 (fr)
WO (1) WO2011018501A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421234B2 (en) * 2011-05-20 2016-08-23 Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
AU2012348700B2 (en) 2011-12-06 2015-08-27 Unilever Plc Skin anti-ageing composition
RU2496469C2 (ru) * 2012-01-11 2013-10-27 Владимир Николаевич Иванов Безабразивная зубная паста, содержащая фермент папаин, экстракт сфагнума, натрий-кальциевую соль сополимера полиметилвинилового спирта и малеиновой кислоты, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид
RU2487698C1 (ru) * 2012-01-11 2013-07-20 Сергей Борисович Улитовский Безабразивная зубная паста, содержащая фермент папаин, экстракт гарпагофитума, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид
US20140212388A1 (en) * 2013-01-30 2014-07-31 Maria Alvarez Prieto Composition For Cosmetic And Health Improvement
CN103230584A (zh) * 2013-03-26 2013-08-07 成进学 钴、铜、硒中药元素维生素外治白癜风的药酒
US9308243B2 (en) * 2014-03-14 2016-04-12 LivePet, LLC Cellular enhancements in biological systems through the use of li-pofullerene and peptide group combinations
WO2015160262A1 (fr) * 2014-04-16 2015-10-22 Amerikal Nutraceutical Corp Composition anti-vieillissement
US10548937B2 (en) 2014-08-20 2020-02-04 Kolinpharma S.P.A. Composition for the treatment of arthropathies and osteoarthritis
CN105853260B (zh) * 2015-01-20 2019-03-05 虞琼斐 一种尿布皮炎霜及其制备方法
TWI605832B (zh) * 2015-06-29 2017-11-21 Caliway Biopharmaceuticals Co Ltd Plant extract composition for desalinating skin and reducing melanin, pharmaceuticals and uses thereof
EP3316879A4 (fr) * 2015-07-01 2019-01-23 TWI Biotechnology, Inc. Formulations topiques de rhéine ou de diacéréine, et utilisations de celles-ci
CN105211120B (zh) * 2015-10-14 2017-11-28 帕潘纳(北京)科技有限公司 植物抑菌增效组合物及其制剂和应用
EP3389624B1 (fr) 2015-12-18 2023-07-26 Mary Kay Inc. Compositions cosmétiques topiques
EP3432860B1 (fr) 2016-03-22 2022-12-21 Avicenna Nutraceutical, LLC Compositions de collagène hydrolysé et leurs procédés de fabrication
WO2018031783A1 (fr) * 2016-08-11 2018-02-15 Almarode Marshall Ollie Compositions et méthodes de traitement et de prévention d'affections cutanées
IT201700055662A1 (it) * 2017-05-23 2018-11-23 Neo G Pharma Srl Composizioni di tipo migliorato per il trattamento topico delle infiammazioni a carico della pelle, degli annessi cutanei, delle mucose in genere, degli annessi oculari e dei conseguenti processi degenerativi.
CA3083357C (fr) * 2017-12-14 2022-06-21 Buckyol Limited Compositions de nanoparticules anisotropes et procedes
US11767314B2 (en) 2018-11-02 2023-09-26 Conopco, Inc. Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same
BR112022007397A2 (pt) * 2019-10-17 2022-09-20 Isp Investments Llc Composição excipiente coprocessada efervescente estável e processo para sua preparação
WO2022173974A1 (fr) * 2021-02-10 2022-08-18 TRI-K Industries, Inc. Nouvelle composition et nouveau procédé contenant des peptides naturels de pois et de quinoa et de la niacinamide pour améliorer l'éclat de la peau, la luminosité et même le teint de la peau
WO2023228217A1 (fr) * 2022-05-27 2023-11-30 Sutar Yogesh Baburao Composition nutraceutique d'acide hyaluronique

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1434955A (fr) 1964-12-02 1966-04-15 Hoffman Taff Procédés de traitement et d'utilisation de résidus végétaux
JPS52148615A (en) 1976-06-07 1977-12-10 Shiyouji Yamashita Aqueous biologically active solution
FR2405068A1 (fr) * 1977-10-10 1979-05-04 Sauba Lab Composition pharmaceutique destinee au traitement du dessechement cutane
FR2648347B1 (fr) * 1989-06-15 1994-04-29 Sederma Sa Preparations cosmetiques possedant des proprietes adoucissantes
FR2678632B1 (fr) * 1991-07-03 1994-09-02 Pharmascience Lab Procede de preparation de l'insaponifiable d'avocat permettant d'ameliorer sa teneur en l'une de ses fractions dite h.
FR2698785B1 (fr) 1992-12-04 1995-02-10 Thorel Jean Noel Composition régulatrice du système mélanocytaire, préparations pharmaceutiques et cosmétiques incorporant une telle composition.
FR2724663B1 (fr) 1994-09-20 1997-01-24 Fabre Pierre Dermo Cosmetique Huile d'argan enrichie, procede de preparation et composition cosmetique la comprenant
FR2762512B1 (fr) 1997-04-24 2000-10-13 Pharmascience Lab Compositions a base d'huile de lupin, notamment a base d'huile de lupin et d'huile de germe de ble et leur utilisation en cosmetologie, en pharmacie et en tant que complement alimentaire
EP1762247A1 (fr) 1998-06-05 2007-03-14 Nutramax Laboratories, Inc. Utilisation d'agents anabolisants, agents anti-cataboliques, agent antioxydant et analgésiques pour la protection, le traitement et la réparation de tissus conjonctifs chez des humains et des animaux
FR2787714B1 (fr) * 1998-12-23 2003-01-31 Pharmascience Lab Utilisation d'insaponifiables d'huiles vegetales pour la preparation d'un medicament stimulant l'expression du tgf-beta ou l'expression de l'inhibiteur pai-1 de l'activateur du plasminogene
WO2000067726A1 (fr) 1999-05-11 2000-11-16 Charles Walton Champ Procedes et formulations hote-invites pour l'administration de composes bioactifs
EP1211955A1 (fr) 1999-08-30 2002-06-12 Ocean Nutrition Canada Ltd. Supplement nutritionnel destine a abaisser le taux de cholesterol et de triglycerides seriques
FR2798667B1 (fr) 1999-09-22 2001-12-21 Pharmascience Lab Procede d'extraction des composes furaniques et alcools gras polyhydroxyles de l'avocat, composition a base de et utilisation de ces composes en therapeutique, cosmetique et alimentaire
FR2798591B1 (fr) * 1999-09-22 2001-10-26 Pharmascience Lab Utilisation d'un produit d'huile vegetale pour augmenter la synthese des lipides cutanes en cosmetique, pharmacie ou dermatologie et en tant qu'additif alimentaire
FR2803598B1 (fr) * 2000-01-12 2002-04-26 Pharmascience Lab Procede d'extraction des insaponifiables des huiles vegetales au moyen de chloro-1-butane, composition comprenant ces insaponifiables
FR2803752B1 (fr) * 2000-01-18 2002-04-12 Pharmascience Lab Utilisation d'au moins un produit d'huile vegetale pour la preparation d'une composition destinee a inhiber l'activite de la 5 alpha-reductase, en pharmacie notamment en dermato- logie,en cosmetique et en tant qu'additif alimentaire
FR2806260B1 (fr) * 2000-03-20 2005-04-08 Pharmascience Lab Utilisation d'une huile vegetale concentree en sa fraction insaponifiable en tant qu'ingredient alimentaire, procede de preparation de cette huile, composition ou complement alimentaire la contenant
IT1317911B1 (it) * 2000-09-28 2003-07-15 Idi Irccs Formulazione cosmetica.
US6994875B2 (en) * 2002-07-29 2006-02-07 Laboratoires Expanscience Process for obtaining a furan lipid-rich unsaponifiable material from avocado
GB0220182D0 (en) 2002-08-30 2002-10-09 Cardiovascular Res Inst Maastr Organic compounds
US20040208939A1 (en) 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
US8075910B2 (en) 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
FR2870742B1 (fr) * 2004-05-28 2008-03-14 Expanscience Laboratoires Sa Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement du diabete, de l'obesite et pour le traitement cosmetique de la cellulite et de la surcharge ponderale
CA2567479C (fr) * 2004-05-28 2012-09-11 Laboratoires Expanscience Utilisation d'alkyle furannes pour la preparation d'un medicament destine au traitement de l'obesite et pour le traitement cosmetique de la surcharge ponderale
DE602005027563D1 (de) 2004-05-28 2011-06-01 Expanscience Lab Verwendung von furanalkylen zur kosmetischen behandlung von zellulitis
FR2873295B1 (fr) * 2004-07-26 2006-12-01 Expanscience Sa Lab Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
FR2885802A1 (fr) 2005-05-17 2006-11-24 Oreal Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau
FR2887749B1 (fr) 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires
FR2887748B1 (fr) * 2005-06-29 2009-09-04 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets des affections articulaires.
ITMI20051416A1 (it) 2005-07-22 2007-01-23 Beauty Farm Del Sorriso S R L Composizioni cosmetiche contenenti acido ialuronico e colostro
FR2893628B1 (fr) * 2005-11-18 2008-05-16 Expanscience Laboratoires Sa Procede d'obtention d'une huile d'avocat raffinee riche en triglycerides et huile susceptible d'etre obtenue par un tel procede
AU2007271900B2 (en) 2006-07-14 2013-05-23 Nattopharma As Pharmaceutical and nutraceutical products comprising vitamin K2
FR2906722B3 (fr) 2006-10-10 2009-04-17 Sephar Sarl Nouvelle composition pharmaceutique et cosmetique et ses applications dermatologiques dans les corrections des epitheliums deshydrates
EP1920756A1 (fr) * 2006-11-07 2008-05-14 Syrio Pharma S.P.A. Matrice cosmétique pour une formule cosmétique sans conservateur
FR2910815B1 (fr) * 2006-12-28 2010-10-29 Expanscience Lab Composition comprenant un extrait de graines de quinoa
WO2009068651A1 (fr) * 2007-11-28 2009-06-04 Dsm Ip Assets B.V. Emulsion de lipide pour la consommation humaine
FR2948566B1 (fr) 2009-07-30 2012-08-10 Expanscience Lab Extrait du fruit de schizandra sphenanthera et compositions cosmetiques, dermatologiques et nutraceutiques le comprenant

Also Published As

Publication number Publication date
ES2658865T3 (es) 2018-03-12
EP2464248A2 (fr) 2012-06-20
US20120141387A1 (en) 2012-06-07
WO2011018501A2 (fr) 2011-02-17
EP2464248B1 (fr) 2017-11-08
FR2949044A1 (fr) 2011-02-18
WO2011018501A3 (fr) 2011-10-20
US9282759B2 (en) 2016-03-15

Similar Documents

Publication Publication Date Title
FR2949044B1 (fr) Composition comprenant une fraction d'insaponifiable
CL2017002939A1 (es) Composiciones farmacéuticas tópicas
BR112015011403A2 (pt) uso de akkermansia para o tratamento de distúrbios metabólicos
CY1119140T1 (el) Συνθεσεις αντικωδικευσης και μεθοδοι κατασκευης και χρησης τους
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
BRPI0819690B8 (pt) uso de uma composição compreendendo cisteamina ou cistamina, ou um sal farmaceuticamente aceitável das mesmas
MX2021006094A (es) Uso de cannabinoides en el tratamiento de epilepsia.
WO2011064402A3 (fr) Extrait de graines d'acacia macrostachya et compositions le comprenant
MX2015001122A (es) Combinaciones farmaceuticas de un inhibidor de cdk4/6 y un inhibidor de b-raf.
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
FR2938193B1 (fr) Medicament ou composition dermatologique comprenant un extrait peptidique d'avocat destine au traitement et a la prevention du prupit
BR112012030641A2 (pt) métodos e composições para terapia farmacêutica oral
BR112014023952A2 (pt) formulações de agentes de ligação à base de igg4 estáveis
FR2969494B1 (fr) Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant
FR2930730B1 (fr) Procede d'obtention d'un extrait de marc de canneberge utilisable notamment dans la prevention et le traitement d'affections telles que caries, gingivites, maux de gorge
MA30035B1 (fr) Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillssement cutane
MA39447A1 (fr) (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
CN102905699A (zh) 抗真菌剂
Chermut et al. Effects of propolis on inflammation markers in patients undergoing hemodialysis: A randomized, double-blind controlled clinical trial
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
MA39448A1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
WO2011052935A3 (fr) Composition destinée à réduire la glycémie, contenant un extrait de smilax china l., de momordica charantia et de cordyceps militaris comme principe actif
MX350145B (es) Extracto proteolitico a partir de bromelaina para el tratamiento de trastornos del tejido conectivo.
BRPI0413714A (pt) frações de leite e preparações de leite para tratamento e/ou prevenção de doenças mediadas por cox-2

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15